| HS Code | 711041 |
| Product Name | The Epicatechin Gallate Has No Epicatechin |
| Category | Dietary Supplement |
| Form | Capsule |
| Active Ingredient | Epicatechin Gallate |
| Net Weight | 60 grams |
| Recommended Dosage | 2 capsules daily |
| Manufacturer | GreenLeaf Naturals |
| Country Of Origin | USA |
| Expiration Period | 24 months |
| Color Of Capsule | White |
| Storage Instructions | Store in a cool, dry place |
As an accredited The Epicatechin Gallate Has No Epicatechin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white, resealable 100g pouch labeled “The Epicatechin Gallate Has No Epicatechin,” features bold black text and hazard symbols. |
| Shipping | The chemical "The Epicatechin Gallate Has No Epicatechin" is shipped in secure, leak-proof containers following safety regulations for laboratory reagents. Packages are cushioned to avoid breakage and labeled with hazard information. Expedited, temperature-controlled shipping may be used to ensure product stability and integrity during transit. Handling instructions are included. |
| Storage | Epicatechin gallate should be stored in a tightly sealed container, protected from light and moisture. Keep it at a temperature between 2–8°C (refrigerated) in a cool, dry, and ventilated area, away from incompatible substances such as strong oxidizing agents. Handling should be minimized to prevent contamination, and proper labeling is essential. Always follow relevant safety and regulatory guidelines. |
Competitive The Epicatechin Gallate Has No Epicatechin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every year, more manufacturers in both the food supplement and pharmaceutical industries ask about the subtle differences in polyphenolic compounds. Our production lines have answered more than a few customer calls about unwanted cross-contaminants in catechin-based raw materials. Epicatechin Gallate (ECG) is usually synthesized along with a small amount of epicatechin present. Many sources overlook this trace impurity, yet in our own experience running large-scale extractions, these small differences shape the outcome of downstream formulations. When the end-use demands precise biological activity or regulatory assurances, such distinctions start to matter in a big way.
Epicatechin itself rarely stays out of the mix when most commercial ECG is produced, especially from crude tea extracts or bulk phenolic concentrates. We’ve spent years perfecting a method that strips away even the residual epicatechin, arriving at a true Epicatechin Gallate—one that leaves out its less complex cousin. The resulting compound, under our control, shows an HPLC peak for ECG and none for epicatechin.
Back when we launched the first batches of what we now call “The Epicatechin Gallate Has No Epicatechin,” we fielded skepticism from some industry veterans who saw this level of separation as extravagant. Once they sent their own samples for third-party analysis, they saw the laboratory results. The product makes a distinct difference for applications sensitive to structure-activity relationships, such as advanced nutraceuticals, standardized drug precursors, and specialized dietary blends.
Pharmaceutical engineers developing controlled-release tablets have told us in direct terms: inconsistent purity changes bioavailability. A stray epicatechin presence, even below 1%, may undermine the repeatability of pharmacokinetic data. During bench-scale pilot runs, the unpredictable overlap between the two molecules—in both solubility and stability—meant surprising spikes or valleys in the measured active ingredient. Since shifting to our pure ECG, they’ve rarely seen such deviations. It all comes back to knowing exactly what lands in the beaker.
Unlike intermediaries or brokered suppliers who often source compounds through multi-layered chains, our chemical process starts and ends inside our own facility. We run the full extraction and purification workflow: selection of the phenolic precursor, strict temperature and pH regulation, followed by fine-tuned chromatographic separation. Our technical staff track every step with the same analytical instruments used at leading third-party labs: HPLC, TLC, and UV-spectrophotometry. Quality never falls beneath the batch threshold we have set internally—substantially higher than regulatory asking limits.
On the ground, our operators have learned to spot which feedstocks are likeliest to create an unwanted epicatechin tail. Over time, feedback from downstream users pushed us to prioritize a method that eliminates just this tail, not just for compliance, but for batch reliability. Foregoing unnecessary thermal cycles or aggressive solvents, we hit the right yield without creating new by-products or losing product integrity.
Some customers who sample run-of-the-mill ECG from bulk traders don’t notice the presence of free epicatechin at first. But in precision industries—where small variances alter product effect—a single stray compound drags real-world costs. Cosmetic companies, for example, spend major resources on skin-safety testing and stability checks. Any deviation leads to repeat protocols, extra analyses, and delayed launches. They want the “cleanest” ECG possible, down to the absence of related, less active catechins.
Food supplement formulators cite the same need. Many seek to support specific bioactive functions, such as anti-inflammatory or antioxidant action. Studies comparing ECG and epicatechin show that they act on different cellular pathways in vitro. While both belong to the flavanol family, research suggests ECG binds with certain enzymes with stronger affinity and lasts longer before breaking down. To control real effects in capsules or functional beverages, eliminating epicatechin ensures each batch matches the published findings. Once word spread about our isolated product, sales to researchers and branded food companies took off.
Noise-free ECG doesn’t just exist in certificate-of-analysis paperwork. Our packing team opens every drum before shipping to visually check the crystal structure and color before the final sealing. Over the years, we have noticed that presence of residual epicatechin—sometimes missed in paperwork—actually changes the crystalline form of ECG ever so slightly. These physical differences matter most when ECG is compressed into tablets or filled as a fine powder into capsules.
Our main product, “The Epicatechin Gallate Has No Epicatechin,” stays stable without caking or lumping, thanks to the elimination of those unwanted side compounds. Manufacturers scaling up to 500-kg lots tell us they see less product loss during mixing and pressing. A couple of our long-standing clients in southern Europe reported lower dust emissions on their automated filling lines, simply because the batch-to-batch consistency discouraged product fines from lifting off in the air.
The primary specification we guarantee: less than 0.05% epicatechin by HPLC, well below the detection threshold for most standard industry tests. Each drum comes marked as “EGC-NEC Series”—our internal code for Epicatechin Gallate, No Epicatechin Contaminant. We offer two forms: a fine white crystalline powder and an ultra-fine granule optimized for rapid dissolution. Both undergo identical purification and testing protocols.
Most buyers come from:
The real separator is process discipline. Most ECG on the market comes from direct tea extraction or partially refined green tea catechin distillates. This approach rolls together multiple polyphenols, including uncontrolled levels of epicatechin, catechin, and minor gallates. Blended ECG carries all of these as traces. Since most suppliers operate by sourcing third-party intermediates, they rely on general spec sheets, not batch-level analytical verification.
Our facility avoids these shortcuts. The extraction starts from a known phenolic precursor with minimal extraneous catechin. Once we hit separation, the purification does not just hit “good enough” but runs to absolute endpoint. The purity profile stays tight no matter the order size. This direct-from-manufacturer approach means a client never discovers after-the-fact that an order does not match the previous shipment.
For context, we once ran parallel comparative tests on our ECG-NEC alongside three samples sourced from major market traders. Only our own showed an epicatechin value below the detection limit across every batch. In some trader samples, the epicatechin-to-ECG ratio reached up to 5%, which would be unacceptable for standardized production lines in Europe or Japan.
Global agencies have increased random spot checks. Not long ago, we heard from a midsize client whose entire tableting batch was held up at customs for an unexplained discrepancy; analysis found minor catechin impurities. The headache rippled through their production schedules. After switching to our batch-pure EGC-NEC, they cleared subsequent inspections without a single hold.
The market landscape has shifted to prioritize not only purity but also source traceability. Big-brand health food companies and pharmaceutical contractors now ask for proof that each lot matches their specifications—right down to the molecular level. Since we oversee the entire process, we can provide chain-of-custody documents and lot-specific analytical results.
Our experience says word spreads fast in these communities. Once a critical mass of buying managers see analytical reproducibility and product stability, orders expand from trial size to multi-ton scale. They come to realize that a less-precise ECG brings unnecessary risk, which, in today’s regulatory climate, is simply too much to carry when an alternative exists.
Staying ahead of evolving requirements keeps us refining our own workflow. Process improvement means embracing both hard science and routine team feedback. For example, one year we noticed our HPLC calibration curve drifted slightly, likely due to an aging detector. Before long, we caught minor variation in the lowest-level contaminants and upgraded key equipment. We treat these as operational lessons, not afterthoughts. It is the direct feedback from those who use our material on the line or in clinical research that sets our priorities, rather than outside consultants or market trends alone.
For end-users facing tough impurity limits or product differentiation challenges, direct supply is the most reliable hedge. Most product recalls related to catechin-based compounds track back to impurity mismatches or undeclared contaminants. A direct line to the manufacturer means transparency and support—without having to navigate multi-layered chain-of-custody documentation. In our case, every drum can be traced back to a single production run manager and a real-time process control report.
We recommend anyone sourcing bulk ECG for regulated formulations require recent, batch-specific analytical data—and not just summary spec sheets. Many global buyers now audit every purchase for true compound identity. An up-to-date chromatogram makes it easy to track changes, intervene rapidly if issues arise, and avoid costly product failures. For us, maintaining such transparency makes more sense than risking reputational damage or recall expenses down the line.
Running a chemical manufacturing operation always means balancing optimization with attention to detail. From the earliest stage, raw materials dictate the output quality. We only procure from verified suppliers whose own cultivation and processing steps we've inspected. Storage conditions—humidity, light, and temperature—are regulated at every stage, minimizing degradation before extraction starts. Our experienced operators cross-check weights and input parameters, reporting directly to a production chemist at each run.
We keep full logs of every equipment maintenance, change in operational settings, and batch result. These records cut through confusion when issues arise, letting us pinpoint problems and fix them before scaling up. Over time, we’ve seen trends—like summer heat shifts affecting extraction yields or specific precursor lots driving up unwanted impurity fractions. Regular team meetings help us share observations and tweak standard parameters, always aimed at maximum reproducibility.
Our technical staff take a pragmatic approach to process design. Instead of favoring speed or headline yield at the expense of purity, we build steps that flag cross-contaminants mid-cycle. We adapted one filtration step after several feedback cycles from tableting manufacturers experiencing end-product clumping. Upgrading to a tighter filter mesh eliminated the residue that caused product sticking and dropped their processing times by 12%. Such improvements accrue slowly, but over time, they create a reputation for stable product quality. Our ECG-NEC owes much to this iterative, practical feedback loop.
With every cycle, we see that single-variable control pays dividends. By engineering a clean ECG, free from epicatechin and other trace polyphenols, we make it possible for downstream users to predict function and reduce batch variability. Tablet pressing runs smoother, analytical tests show less lot-to-lot drift, and final product shelf-life extends by measurable margins. Brand owner feedback supports this: clearer ingredient panels, fewer consumer complaints, fewer regulatory headaches.
Beyond these immediate benefits, choosing a truly pure ECG allows further product innovation. Food formulators can pursue new health claims based on research that only pertains to the gallate form, not confounded by the presence of plain epicatechin. Pharmaceutical researchers find clean data points that match their reference standards. For us, seeing our work contribute to focused research or distinctive end-products is a reward in its own right.
Our team has watched polyphenol markets change as technology, regulation, and end-user demands evolve. In years past, a single analytical test and paperwork could clear a shipment. Today, informed clients set the bar higher—asking about crystal structure, minor contaminant identification, and even process flow diagrams. We meet these demands without hedging, because our workflow was built for traceability and repeatability before these requirements came to the forefront.
The existence of “The Epicatechin Gallate Has No Epicatechin” proves technical nuances matter on the ground. Achieving this pure form requires real process expertise, persistent investment in analytical equipment, and careful management of feedback from users in the field. Every month, we receive requests for new certificate formats, technical clarifications, or batch samples for pilot runs. This two-way channel between production chemists and end-users underpins how we operate.
As new applications for pure polyphenols emerge—from personalized medicine to specialized functional foods—we keep our lines open to those pushing the next wave of formulations. Direct conversations with on-the-ground process engineers, research chemists, and product developers provide the real insight that guides our continuous improvement. It’s these relationships that ensure “The Epicatechin Gallate Has No Epicatechin” stands apart, not just by specification, but by performance in the world’s most demanding product lines.